aspirin has been researched along with Glomerulonephritis, Membranous in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A tool for evaluating the risk of bleeding in patients with MN was proposed in the KDIGO 2021 guideline, and individuals with low risk of bleeding as well as high risk of VTE were suggested to use warfarin or low-molecular-weight heparin (LMWH) combined with aspirin, as an alternative regimen for warfarin." | 4.31 | Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow? ( Li, X; Shao, H; Wang, G; Xie, X; Zhang, X; Zhao, Y, 2023) |
| "Patients with nephrotic syndrome are at increased risk of thrombosis." | 1.43 | Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy? ( Hofstra, JM; Wetzels, JFM, 2016) |
| "Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h protein excretion; the latter amounted to 54% with dipyridamole alone and 56% with dipyridamole plus aspirin (NS)." | 1.28 | Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis. ( Cámara, S; De La Cruz, JP; Frutos, MA; Sánchez De La Cuesta, F, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 2 |
| Xie, X | 1 |
| Zhao, Y | 1 |
| Wang, G | 1 |
| Shao, H | 1 |
| Zhang, X | 1 |
| Zou, P | 1 |
| Li, H | 1 |
| Cai, J | 1 |
| Li, C | 1 |
| Chen, Z | 1 |
| Hofstra, JM | 1 |
| Wetzels, JFM | 1 |
| De La Cruz, JP | 1 |
| Cámara, S | 1 |
| Frutos, MA | 1 |
| Sánchez De La Cuesta, F | 1 |
4 other studies available for aspirin and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow?
Topics: Anticoagulants; Aspirin; Glomerulonephritis, Membranous; Hemorrhage; Heparin, Low-Molecular-Weight; | 2023 |
The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy.
Topics: Adult; Aged; Aspirin; Beijing; Female; Glomerulonephritis, Membranous; Heparin, Low-Molecular-Weight | 2019 |
Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
Topics: Anticoagulants; Aspirin; Glomerulonephritis, Membranous; Humans; Nephrotic Syndrome; Primary Prevent | 2016 |
Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hum | 1992 |